Pavan Cheruvu, Principal Executive Officer at Axovant Gene Therapies Ltd. (AXGT), bought 75,000 shares at $2.74 ($206K) on 2020-07-08, disclosed to the SEC on 2020-07-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.74 | 37,500 | $103K | 50.0% |
| 2 | $2.74 | 37,500 | $103K | 50.0% |
| Total | $2.74 avg | 75,000 | $206K | 100% |
| Filing → |